DIN 02564521 — APO-NAPROXEN / ESOMEPRAZOLE 20 MG; 375 MG
APO-NAPROXEN / ESOMEPRAZOLE is a tablet (immediate- and delayed-release) of Naproxen / Esomeprazole marketed by APOTEX INC. The full Naproxen / Esomeprazole monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02564521
- Brand name
- APO-NAPROXEN / ESOMEPRAZOLE
- Active ingredient
- Naproxen / Esomeprazole
- Strength
- 20 MG; 375 MG
- Dosage form
- TABLET (IMMEDIATE- AND DELAYED-RELEASE)
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- NSAID with proton pump inhibitor (fixed-dose combination)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Naproxen / Esomeprazole products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02564548 | APO-NAPROXEN / ESOMEPRAZOLE | 500 MG; 20 MG | TABLET (IMMEDIATE- AND DELAYED-RELEASE) | APOTEX INC | MARKETED |
| 02443449 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 20 MG; 500 MG | TABLET (IMMEDIATE- AND DELAYED-RELEASE) | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02458608 | MYLAN-NAPROXEN/ESOMEPRAZOLE MR | 375 MG; 20 MG | TABLET (IMMEDIATE- AND DELAYED-RELEASE) | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02361701 | VIMOVO | 20 MG; 375 MG | TABLET (IMMEDIATE- AND DELAYED-RELEASE) | XEDITON PHARMACEUTICALS INC | MARKETED |
| 02361728 | VIMOVO | 20 MG; 500 MG | TABLET (IMMEDIATE- AND DELAYED-RELEASE) | XEDITON PHARMACEUTICALS INC | MARKETED |